arginine has been researched along with Lymphoma, B-Cell in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balhorn, R; Corzett, M; Denardo, G; DeNardo, S; Hok, S; Mirick, G; Natarajan, A | 1 |
| Bulur, PA; Dietz, AB; Gastineau, DA; Gustafson, MP; Lin, Y; Witzig, TE | 1 |
| Baralle, D; Bonthron, DT; Charlton, R; Cole, TR; De Vos, M; Glaser, AW; Hayward, BE; Maher, ER; Mann, JR; McKeown, CM; Picton, S; Rankin, J; Sheridan, E; Taylor, GR; Yates, JR | 1 |
| Harada, S; Kieff, E; Tong, X; Yalamanchili, R | 1 |
| Ba, Y; Hou, Y; Wang, HQ | 1 |
| Bibeau, F; Cebotaru, C; El Weshi, A; Fadel, C; Fenaux, P; Frayfer, J; Laribi, K; Ribrag, V | 1 |
6 other study(ies) available for arginine and Lymphoma, B-Cell
| Article | Year |
|---|---|
Hexa-arginine enhanced uptake and residualization of selective high affinity ligands by Raji lymphoma cells.
Topics: Arginine; Binding Sites; Cell Line, Tumor; Cell Nucleus; Heterocyclic Compounds, 1-Ring; HLA-DR Antigens; HLA-DR Serological Subtypes; Humans; Ligands; Lymphoma, B-Cell; Microscopy, Confocal; Oligopeptides; Peptides | 2009 |
Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.
Topics: Arginase; Arginine; Cell Proliferation; Cells, Cultured; Flow Cytometry; HLA-DR Antigens; Humans; Immunophenotyping; Immunosuppression Therapy; Interferon-alpha; Interferon-gamma; Interleukin-6; Lipopolysaccharide Receptors; Lymphoma, B-Cell; Monocytes; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; STAT1 Transcription Factor; T-Lymphocytes | 2011 |
PMS2 mutations in childhood cancer.
Topics: Adenosine Triphosphatases; Adolescent; Arginine; Astrocytoma; Cafe-au-Lait Spots; Child; Colonic Polyps; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; Female; Founder Effect; Genetic Predisposition to Disease; Glioma; Humans; Leukemia, T-Cell; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Mismatch Repair Endonuclease PMS2; Mutation; Neoplasms; Neoplasms, Second Primary; Pakistan; Precursor Cell Lymphoblastic Leukemia-Lymphoma; United Kingdom | 2006 |
The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
Topics: Amino Acid Sequence; Antigens, Viral; Arginine; Base Sequence; Binding Sites; Burkitt Lymphoma; Cell Line; Cell Nucleus; Cell Transformation, Viral; Chloramphenicol O-Acetyltransferase; Cosmids; DNA Primers; DNA-Binding Proteins; Epstein-Barr Virus Nuclear Antigens; Glutathione Transferase; Glycine; Herpesvirus 4, Human; Humans; Lymphoma, B-Cell; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Recombinant Fusion Proteins; Repetitive Sequences, Nucleic Acid; Restriction Mapping; Sequence Deletion; Transfection; Tumor Cells, Cultured | 1994 |
Comparison on therapeutic effects of RFT and RCTVP regimen in the treatment of patients with indolent B-cell lymphoma in China.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Prednisolone; Rituximab; Teniposide; Vidarabine | 2012 |
Primary breast lymphoma: a report of 20 cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Middle Aged; Prednisone; Prognosis; Recurrence; Retrospective Studies; Survival Rate; Teniposide; Treatment Outcome; Vincristine | 2001 |